RRM2 and pancreatic adenocarcinoma: In addition, inhibition of RRM2 mRNA expression in vitro with the use of interference RNA enhanced chemosensitivity of pancreatic adenocarcinomas to gemcitabine (Duxbury et al, 2003, 2004).